404 related articles for article (PubMed ID: 18972629)
21. Decongestive effects of levosimendan in cardiogenic shock induced by postpartum cardiomyopathy.
Labbene I; Arrigo M; Tavares M; Hajjej Z; Brandão JL; Tolppanen H; Feliot E; Gayat E; Ferjani M; Mebazaa A
Anaesth Crit Care Pain Med; 2017 Feb; 36(1):39-42. PubMed ID: 27436451
[TBL] [Abstract][Full Text] [Related]
22. Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction.
Abdel-Wahab M; Saad M; Kynast J; Geist V; Sherif MA; Richardt G; Toelg R
Am J Cardiol; 2010 Apr; 105(7):967-71. PubMed ID: 20346314
[TBL] [Abstract][Full Text] [Related]
23. Management of acute cardiac failure by intracoronary administration of levosimendan.
Caimmi PP; Kapetanakis EI; Beggino C; Molinari C; Giustini G; Crosio E; Reposo G; Micalizzi E; Vacca G; Grossini E
J Cardiovasc Pharmacol; 2011 Sep; 58(3):246-53. PubMed ID: 21654504
[TBL] [Abstract][Full Text] [Related]
24. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
Meyer K; Klocke RC; Schipke JD; Gams E; Korbmacher B
Eur J Cardiothorac Surg; 2008 Aug; 34(2):326-31. PubMed ID: 18539040
[TBL] [Abstract][Full Text] [Related]
25. [Impact of the intra-aortic balloon pump in the mortality due to cardiogenic shock secondary to acute myocardial infarction].
Arias EA; González-Chon O; García-López SM; Chacón MA; Noriega-Iriondo F; Vega RE; Chávez-Tapia NC
Arch Cardiol Mex; 2005; 75(3):260-6. PubMed ID: 16294814
[TBL] [Abstract][Full Text] [Related]
26. Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines.
Delle Karth G; Buberl A; Geppert A; Neunteufl T; Huelsmann M; Kopp C; Nikfardjam M; Berger R; Heinz G
Acta Anaesthesiol Scand; 2003 Nov; 47(10):1251-6. PubMed ID: 14616323
[TBL] [Abstract][Full Text] [Related]
27. Levosimendan in cardiogenic shock: the magic drug for every patient?
Smetana P; Geppert A
Crit Care Med; 2007 Dec; 35(12):2862-4. PubMed ID: 18043208
[No Abstract] [Full Text] [Related]
28. Mechanical versus pharmacologic support for cardiogenic shock.
Dhar G; Jolly N
Catheter Cardiovasc Interv; 2010 Mar; 75(4):626-9. PubMed ID: 20049971
[TBL] [Abstract][Full Text] [Related]
29. Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATP-channel activation but is independent of PDE-III inhibition.
Hönisch A; Theuring N; Ebner B; Wagner C; Strasser RH; Weinbrenner C
Basic Res Cardiol; 2010 Mar; 105(2):155-67. PubMed ID: 19842009
[TBL] [Abstract][Full Text] [Related]
30. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
Follath F
Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
[TBL] [Abstract][Full Text] [Related]
31. [Cardiogenic shock-- new therapeutic strategies].
Andersen GØ; Eritsland J; Bjørnerheim R; Kløw NE; Jonassen A; Mangschau A
Tidsskr Nor Laegeforen; 2005 May; 125(10):1318-21. PubMed ID: 15909001
[TBL] [Abstract][Full Text] [Related]
32. Hemodynamic effects of sulmazol (ARL-115 BS), a new vasodilator and positive inotropic agent, in patients with cardiogenic shock.
Simoons ML; Muskens G; Hugenholtz PG
Herz; 1983 Feb; 8(1):34-40. PubMed ID: 6832691
[TBL] [Abstract][Full Text] [Related]
33. [Short and intermediate term clinical outcome in patients with cardiogenic shock treated with aortic counterpulsation].
Fornaro G; Prando MD; Parodi F; Cordero G; Sansa M; Bongo AS; Campi A; Aralda D; Dellavesa P; Aina F; Lazzero M; Cernigliaro C
G Ital Cardiol; 1996 Dec; 26(12):1385-99. PubMed ID: 9162668
[TBL] [Abstract][Full Text] [Related]
34. Treatment of cardiogenic shock with levosimendan in combination with beta-adrenergic antagonists.
Alhashemi JA
Br J Anaesth; 2005 Nov; 95(5):648-50. PubMed ID: 16143579
[TBL] [Abstract][Full Text] [Related]
35. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
Schumann J; Henrich EC; Strobl H; Prondzinsky R; Weiche S; Thiele H; Werdan K; Frantz S; Unverzagt S
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD009669. PubMed ID: 29376560
[TBL] [Abstract][Full Text] [Related]
36. Levosimendan versus intra-aortic balloon pump in high-risk cardiac surgery patients.
Severi L; Lappa A; Landoni G; Di Pirro L; Luzzi SJ; Caravetta P; Cipullo P; Menichetti A
J Cardiothorac Vasc Anesth; 2011 Aug; 25(4):632-6. PubMed ID: 21546269
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of intra-aortic balloon pump counterpulsation in patients with cardiogenic shock from acute myocardial infarction.
Cheng JM; Valk SD; den Uil CA; van der Ent M; Lagrand WK; van de Sande M; van Domburg RT; Simoons ML
Am J Cardiol; 2009 Aug; 104(3):327-32. PubMed ID: 19616662
[TBL] [Abstract][Full Text] [Related]
38. The clinical experience with levosimendan in anesthesiology and in the intensive care unit.
Cavana M; Pignataro C; Fraticelli A; Mebazaa A
Ital Heart J; 2003 May; 4 Suppl 2():61S-64S. PubMed ID: 14635372
[TBL] [Abstract][Full Text] [Related]
39. Effect of prolonged intra-aortic balloon pumping in patients with cardiogenic shock following acute myocardial infarction.
Li JL; Xue H; Wang BS; Zhang HY; Yin LH; Shun WD; Wu Y; Wang LX
Med Sci Monit; 2007 Jun; 13(6):CR270-74. PubMed ID: 17534233
[TBL] [Abstract][Full Text] [Related]
40. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock.
Thiele H; Sick P; Boudriot E; Diederich KW; Hambrecht R; Niebauer J; Schuler G
Eur Heart J; 2005 Jul; 26(13):1276-83. PubMed ID: 15734771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
